Cannabis Use in the Childbearing Years: An Evidence Summary for Healthcare Providers
Due to the legalization of cannabis in Canada, and for the health of children and families, there is a growing need to provide parents, prospective parents, healthcare professionals, and other service providers with evidence-based information about the potential risks of cannabis use. This evidence summary is for healthcare providers. It provides general information about cannabis and rates of cannabis use in Canada, as well as information about the potential risks of cannabis use before, during, and after pregnancy. This summary also offers several recommendations for public messaging based on the available research.
HIV: Healthy Pregnancies and Healthy Babies
This booklet is designed for women living with HIV who are planning a pregnancy or are already pregnant. Topics include basic HIV and HIV treatment information, how to stay healthy before and during pregnancy, unique issues that may face women living with HIV, and where to go for more information and support. The booklet is an update to the previous HIV and pregnancy-related pamphlets provided by the Saskatchewan Prevention Institute.SKU: 7-005
Vertical (Mother-to-child) Transmission of HIV: Prevention, Treatment, and Education
Saskatchewan continues to see high rates of new cases of human immunodeficiency virus (HIV) infection in comparison to the rest of Canada. A large number of these new cases are being identified in women of childbearing age.
Recognizing the importance of understanding HIV in the context of pregnancy, the Saskatchewan Prevention Institute conducted a review of the literature in this area. The review includes findings and recommendations on vertical transmission, transmission prevention, barriers to prevention, and health promotion around these topics.Download the Vertical Transmission Executive SummarySKU: 7-501
The Impact of Substance Use on Mother-to-child Transmission of HIV
This literature review aimed to assess the impact of substance use on mother-to-child transmission (MTCT) of HIV. Such a review was deemed necessary due to Saskatchewan’s unique HIV profile. Specifically, new cases of HIV in Saskatchewan are: (a) the highest in Canada; (b) most often associated with injection drug use (IDU); and (c) increasing rapidly in women of childbearing age (ages 15 to 39). The primary questions addressed in the report include: Why do substance use services need to be focused on to avoid MTCT of HIV? How does having a substance use issue influence high risk behaviours that can lead to HIV infection? How does having a substance use issue affect virus progression and impact the health of pregnant women living with HIV?SKU: 7-508